Clinical Trials Directory

Trials / Completed

CompletedNCT05111535

Stockholm Acute Kidney Injury Cohort

Stockholm Prospective Acute Kidney Injury Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,861 (actual)
Sponsor
Danderyd Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since 2009, adult patients with acute kindney injury (AKI) at the department of Nephrology, Danderyd University Hospital and Karolinska Institutet, have been included in a prospective cohort. All patients were treated and evaluated according to a detailed clinical memorandum, and data collected prospectively. By 2020, 1861 patiens have been included of which 1519 fulfill current AKI criteria (as defined by KDIGO AKI guidelines) and will be evaluated regarding the following main research questions: 1. Descriptive study on patient characteristics, changes in biomarkers and in-hospital outcome. 2. One year outcome with focus on renal and cardiovascular outcomes. 3. Long-term outcome (up to 10 years) with focus on renal and cardiovascular outcomes.

Detailed description

Acure kidney injury (AKI) remains a complex clinical challenge associated with high risk for short-term and long-term adverse events. Since 2009 patients with AKI at the department of Nephrology, Danderyd University Hospital and Karolinska Institutet, have been included in a prospective cohort. Adult patients with either s-creatinine \>130 micromol/L and previously unknown level, or 30% increase from previous known level were included; patients on dialysis were not included. All patients were treated and evaluated according to a detailed clinical memorandum, and data collected prospectively. By 2020, 1861 patiens have been included of which 1519 fulfill current AKI criteria and will be evaluated regarding the following main research questions: 1. Descriptive study on in-hospital outcome (death, renal recovery), patient characteristics, hyperkalemia and changes in biomarkers reflecting inflammation, acidosis and malnutrition. 2. One year outcome with focus on renal and cardiovascular outcomes (death, new dialysis, worsened renal function, myocardial infarction, stroke, or heart failure; MARCE). 3. Long-term outcome (up to 10 years) with focus on renal and cardiovascular outcomes (MARCE).

Conditions

Timeline

Start date
2009-01-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2021-11-08
Last updated
2021-11-08

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05111535. Inclusion in this directory is not an endorsement.